Work

P246: Challenges in establishing best practices for gene therapy informed consent for hemophilia A/B

Year: 2024
Type: conference-abstract
Abstract: FDA approved gene therapy treatment for adults with hemophilia B became available in November 2022 and June 2023 for hemophilia A, and additional competing gene therapy clinical trials are underway. Unlike other genetic disorders for which gene therapy is available, hemophilia A and B each have effective alternative treatment options that have more long-term safety and efficacy data. Additionally, there may eventually be competing options for gene therapies that could further improve clinical outcomes.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,200
OpenAlex ID: W4392589134
Cites:
Cited by: 1
Related to: 10